Elevation Point Wealth Partners LLC Buys Shares of 30,650 Aflac Incorporated $AFL

Key Points

• Elevation Point Wealth Partners purchased 30,650 Aflac shares worth approximately $3.6 million, while institutional investors collectively own 67.44% of the company.
• Analyst sentiment remains cautious: Aflac has a consensus “Hold” rating and an average price target of $116.62, with recent targets ranging from $103 to $124.
• Aflac reported $1.75 in quarterly EPS, slightly below estimates, while revenue of $4.22 billion exceeded expectations; the company also declared a quarterly dividend of $0.61 per share, yielding about 2.1%.

Elevation Point Wealth Partners LLC purchased a new position in shares of Aflac Incorporated (NYSE:AFL - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund purchased 30,650 shares of the financial services provider's stock, valued at approximately $3,594,000.

A number of other institutional investors and hedge funds have also modified their holdings of AFL. DNB Asset Management AS boosted its holdings in Aflac by 51.3% during the fourth quarter. DNB Asset Management AS now owns 168,003 shares of the financial services provider's stock worth $18,526,000 after buying an additional 56,975 shares during the last quarter. Employees Retirement System of Texas bought a new stake in shares of Aflac in the 4th quarter valued at about $3,743,000. Atlas Wealth LLC bought a new stake in shares of Aflac in the 1st quarter valued at about $1,802,000. D.A. Davidson & CO. raised its position in shares of Aflac by 77.3% in the 4th quarter. D.A. Davidson & CO. now owns 63,646 shares of the financial services provider's stock valued at $7,018,000 after acquiring an additional 27,751 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. raised its position in shares of Aflac by 4.5% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,072,717 shares of the financial services provider's stock valued at $118,256,000 after acquiring an additional 46,262 shares during the period. 67.44% of the stock is owned by institutional investors.

Analysts Set New Price Targets

AFL has been the subject of several recent analyst reports. UBS Group reaffirmed a "neutral" rating and issued a $124.00 target price (up from $114.00) on shares of Aflac in a research note on Wednesday, July 8th. Weiss Ratings cut shares of Aflac from a "buy (a-)" rating to a "buy (b+)" rating in a research report on Friday, August 7th. Wolfe Research began coverage on shares of Aflac in a report on Wednesday. They issued an "underperform" rating and a $103.00 price target for the company. JPMorgan Chase & Co. lowered their price objective on shares of Aflac from $117.00 to $116.00 and set a "neutral" rating for the company in a research report on Tuesday, August 11th. Finally, Jefferies Financial Group reaffirmed a "hold" rating and set a $108.00 price objective (up from $100.00) on shares of Aflac in a research note on Friday, July 10th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, seven have assigned a Hold rating and three have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, Aflac currently has a consensus rating of "Hold" and an average target price of $116.62.

Insider Activity

In other Aflac news, Director Joseph L. Moskowitz sold 600 shares of the business's stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $124.10, for a total value of $74,460.00. Following the sale, the director owned 32,710 shares in the company, valued at approximately $4,059,311. The trade was a 1.80% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, major shareholder Post Holdings Co. Ltd. Japan sold 12,700 shares of the company's stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $117.05, for a total value of $1,486,535.00. Following the transaction, the insider directly owned 50,817,790 shares of the company's stock, valued at approximately $5,948,222,319.50. This trade represents a 0.02% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 497,625 shares of company stock worth $58,356,483 in the last three months. Company insiders own 0.80% of the company's stock.

Key Aflac News

Here are the key news stories impacting Aflac this week:

• Positive Sentiment: Aflac’s quarterly dividend is $0.61 per share, or $2.44 annualized, providing a yield of roughly 2.1%. The company has a long record of dividend growth and a relatively low payout ratio of about 26%, supporting its appeal as a defensive income stock.
• Neutral Sentiment: Recent earnings were mixed: quarterly revenue of $4.22 billion exceeded analyst expectations of $4.11 billion, but earnings per share of $1.75 narrowly missed the $1.76 consensus. Revenue declined 1% year over year and EPS fell from $1.78 in the prior-year quarter, limiting fundamental momentum.
• Neutral Sentiment: Wall Street’s overall view remains cautious, with a consensus rating of “Hold” and an average price target near $116.62. Some analysts remain constructive, including Piper Sandler with a $138 target, while others maintain neutral or underweight ratings.
• Negative Sentiment: Wolfe Research initiated coverage with an “underperform” rating and a $103 price target, implying meaningful downside from recent trading levels. The call adds to existing concerns from Barclays and JPMorgan, which also have cautious ratings or targets. Wolfe Research Starts Aflac at Underperform
• Negative Sentiment: Japan Post Holdings, Aflac’s major shareholder, sold another 12,700 shares on August 19 for approximately $1.49 million, following sales of 14,200 shares on August 18 and 13,900 shares on August 17. The transactions were conducted under a pre-arranged Rule 10b5-1 plan and represent only a small reduction in its stake, but the repeated selling may weigh on investor sentiment. Aflac SEC Insider Filing

Aflac Stock Performance

Shares of AFL stock opened at $116.12 on Friday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.12 and a current ratio of 0.12. The company has a market capitalization of $58.22 billion, a P/E ratio of 12.45, a price-to-earnings-growth ratio of 1.87 and a beta of 0.60. The company's 50 day moving average price is $121.55 and its two-hundred day moving average price is $116.12. Aflac Incorporated has a 52 week low of $104.66 and a 52 week high of $130.22.

Aflac (NYSE:AFL - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The financial services provider reported $1.75 earnings per share for the quarter, missing the consensus estimate of $1.76 by ($0.01). Aflac had a net margin of 26.91% and a return on equity of 13.27%. The company had revenue of $4.22 billion during the quarter, compared to analyst estimates of $4.11 billion. During the same quarter last year, the company earned $1.78 EPS. The firm's quarterly revenue was down 1.0% compared to the same quarter last year. On average, analysts expect that Aflac Incorporated will post 7.04 earnings per share for the current fiscal year.

Aflac Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 1st. Shareholders of record on Wednesday, August 19th will be issued a dividend of $0.61 per share. This represents a $2.44 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date is Wednesday, August 19th. Aflac's dividend payout ratio is 26.15%.

Aflac Company Profile

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac's product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source